Predicting worsening risk in MGFA class I, II and III myasthenia gravis patients: development and validation of a predictive nomogram
Прогнозирование риска ухудшения у пациентов с миастенией (классы MGFA I, II и III): разработка и валидация прогностической номограммы
2025-04-30
SCID: 54.1/9g8y58dv
Discuss with AI
MGFA class I II IIImulticenter prospective validationmyasthenia gravispredictive nomogramworsening risk stratification
Figures from the paper
Abstract (AI)
This nomogram integrates accessible clinical variables to stratify MG worsening risk, enabling early intervention. Validation through multicenter prospective studies is warranted to optimize generalizability.
Key Findings
1
A predictive nomogram was developed to estimate risk of worsening in MGFA class I, II, and III myasthenia gravis patients using accessible clinical variables.
2
The model was validated (implying internal or initial validation), but multicenter prospective studies are needed to confirm and optimize generalizability.
3
The nomogram enables stratification of patients by worsening risk to support early intervention decisions.
Research Object
Patients with myasthenia gravis classified as MGFA class I, II and III
Research Subject
Development and validation of a predictive nomogram to stratify risk of disease worsening
Publication Details
Publication Date
2025-04-30
Journal
Publisher
ISSN
Cited by
1
Access Type
Author Information
Download PDF
Subscribe to digest